Shanghai Junshi Biosciences Statistics
Total Valuation
Shanghai Junshi Biosciences has a market cap or net worth of HKD 23.59 billion. The enterprise value is 22.93 billion.
Market Cap | 23.59B |
Enterprise Value | 22.93B |
Important Dates
Earnings Date | n/a |
Ex-Dividend Date | n/a |
Share Statistics
Shanghai Junshi Biosciences has 984.87 million shares outstanding. The number of shares has increased by 3.06% in one year.
Shares Outstanding | 984.87M |
Shares Change (YoY) | +3.06% |
Shares Change (QoQ) | +1.84% |
Owned by Insiders (%) | 19.99% |
Owned by Institutions (%) | 18.00% |
Float | 571.58M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 6.05 |
PB Ratio | 1.51 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -11.05 |
EV / Sales | 13.18 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -7.99 |
Financial Position
The company has a current ratio of 2.11, with a Debt / Equity ratio of 38.90.
Current Ratio | 2.11 |
Quick Ratio | 1.73 |
Debt / Equity | 38.90 |
Debt / EBITDA | n/a |
Debt / FCF | -0.96 |
Interest Coverage | -53.89 |
Financial Efficiency
Return on equity (ROE) is -27.25% and return on invested capital (ROIC) is -12.86%.
Return on Equity (ROE) | -27.25% |
Return on Assets (ROA) | -10.94% |
Return on Capital (ROIC) | -12.86% |
Revenue Per Employee | 687,009 |
Profits Per Employee | -819,441 |
Employee Count | 2,568 |
Asset Turnover | 0.14 |
Inventory Turnover | 0.98 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -48.31% in the last 52 weeks. The beta is 0.35, so Shanghai Junshi Biosciences's price volatility has been lower than the market average.
Beta (5Y) | 0.35 |
52-Week Price Change | -48.31% |
50-Day Moving Average | 11.95 |
200-Day Moving Average | 13.59 |
Relative Strength Index (RSI) | 37.67 |
Average Volume (20 Days) | 981,722 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Shanghai Junshi Biosciences had revenue of HKD 1.74 billion and -2.07 billion in losses. Loss per share was -2.11.
Revenue | 1.74B |
Gross Profit | 1.10B |
Operating Income | -2.14B |
Pretax Income | -2.15B |
Net Income | -2.07B |
EBITDA | -1.85B |
EBIT | -2.14B |
Loss Per Share | -2.11 |
Balance Sheet
The company has 3.56 billion in cash and 2.76 billion in debt, giving a net cash position of 797.59 million or 0.81 per share.
Cash & Cash Equivalents | 3.56B |
Total Debt | 2.76B |
Net Cash | 797.59M |
Net Cash Per Share | 0.81 |
Equity (Book Value) | 7.10B |
Book Value Per Share | 7.07 |
Working Capital | 2.72B |
Cash Flow
In the last 12 months, operating cash flow was -1.77 billion and capital expenditures -1.10 billion, giving a free cash flow of -2.87 billion.
Operating Cash Flow | -1.77B |
Capital Expenditures | -1.10B |
Free Cash Flow | -2.87B |
FCF Per Share | -2.91 |
Margins
Gross margin is 63.39%, with operating and profit margins of -123.07% and -119.28%.
Gross Margin | 63.39% |
Operating Margin | -123.07% |
Pretax Margin | -123.48% |
Profit Margin | -119.28% |
EBITDA Margin | -106.51% |
EBIT Margin | -123.07% |
FCF Margin | -165.02% |
Dividends & Yields
Shanghai Junshi Biosciences does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -3.06% |
Shareholder Yield | -3.06% |
Earnings Yield | -19.70% |
FCF Yield | -27.24% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |